share_log

Connect Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wubin Pan(11.1%),BioFortune Inc.(10.8%)

康乃德生物 | SC 13G:超过5%持股股东披露文件-Wubin Pan(11.1%),BioFortune Inc.(10.8%)

2022/02/25 16:42
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息